Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 752 of 6351
-
Blood test may spot lung cancer early, avoiding unnecessary biopsies
Diagnosis Recruiting nowThe goal of the NIMBLE study is to evaluate blood-based biomarkers for lung cancer risk prediction in patients referred with a lung nodule. Each blood biomarker will be evaluated for descriminating malignant from benign lung nodules alone and in combination with other blood biom…
Sponsor: Herlev and Gentofte Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New targeted pill shows promise for tough lung cancer
Disease control Recruiting nowA first in human study to evaluate the safety and preliminary antitumor activity of BBO-8520, a KRAS G12C (ON and OFF) inhibitor, as a single agent and in combination with pembrolizumab and BBO-10203 in subjects with locally advanced and unresectable or metastatic non-small cell …
Phase 1 • Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New program aims to boost HIV viral suppression in latino community
Disease control Recruiting nowThe goal of this study is to test the effectiveness of ADELANTE on viral suppression among Latinos with HIV and viral non-suppression. Participants will receive ADELANTE (5-session, community health worker-delivered, problem-solving intervention) or enhanced care condition (ECC, …
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for brain cancer patients: drug combo targets aggressive tumors
Disease control OngoingThe trial aims to collect safety, efficacy, exposure, dose- response, pharmacokinetic and pharmacodynamic information of the combination of L19TNF and lomustine at different dose levels in patients with Glioblastoma at progression or recurrence
Phase 2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Mindfulness may offer relief for long COVID sufferers
Symptom relief Recruiting nowThis research is being done to study a mindfulness intervention among people who have symptoms of Post-Acute Sequelae of SARS-CoV-2 infection (PASC), also known as Long COVID. Mindfulness is defined as paying attention to the present moment with non-judgment and acceptance. Here …
Sponsor: Columbia University • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
New hope for Hard-to-Treat merkel cell cancer: drug combo trial underway
Disease control OngoingThis phase II trial compares tuvusertib in combination with avelumab to tuvusertib alone to determine whether the combination therapy will lengthen the time before the cancer starts getting worse in patients with Merkel cell cancer that has not responded to previous treatment (re…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug may boost recovery in kids with rare bone marrow failure
Disease control Recruiting nowThe purpose of this study is to find out whether upfront emapalumab treatment can help in sAA (Aplastic Anemia) treatment planning and increase the effectiveness of standard treatment options. Funding Source- FDA OOPD
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug duo aims to slow rare spleen cancer
Disease control OngoingThe goal of this clinical trial is to compare the efficacy and tolerability of the combination of two medicinal products, rituximab, and zanubrutinib, compared to rituximab monotherapy in patients with Splenic Marginal Zone Lymphoma (SMZL), previously untreated and who need syste…
Phase 3 • Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could High-Dose testosterone boost chemo against Hard-to-Treat prostate cancer?
Disease control Recruiting nowThis phase II trial studies how well giving testosterone at levels higher than normally found in the body (supraphysiological) works to enhance chemotherapy treatment, and Lutetium 177Lu-prostate specific-membrane antigen (PSMA)-617 (LuPSMA) in patients with prostate cancer that …
Phase 2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Food flavors on the breath may reveal hidden liver disease
Diagnosis CompletedThe Early Liver Disease Breath Detection Study is a cross-sectional study where subjects with advanced liver fibrosis will ingest a mixture of food-grade compounds (known as Exogenous Volatile Organic Compound or EVOCs) in the form of an emulsion and then provide multiple breath …
Sponsor: Owlstone Ltd • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Could a monthly cash gift end homelessness for families with babies?
Disease control OngoingThe Growing Strong program tests a novel approach to helping families with young children living in homeless shelters, namely offering guaranteed, unconditional cash gifts that families can use as they wish plus voluntary peer support. The assumption behind this approach is that …
Sponsor: Vanderbilt University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can an arthritis drug quiet the pain of chronic pancreatitis?
Symptom relief OngoingThis placebo-controlled study will investigate the effect of tocilizumab (an anti-interleukin-6 receptor antibody) on symptom burden, physical functioning, and quality of life in patients with chronic pancreatitis.
Phase 2 • Sponsor: Soren Schou Olesen • Aim: Symptom relief
Last updated Aug 16, 2026 00:00 UTC
-
New shot every 3 months could tame high blood fats
Disease control OngoingThis Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with hypertriglyceridemia (HTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or …
Phase 3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New hope for Hard-to-Treat lymphoma: Three-Drug combo enters human testing
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of mosunetuzumab when given together with polatuzumab vedotin and lenalidomide in treating patients with diffuse large B-cell lymphoma (DLBCL) that has come back after a period of improvement (relapsed) or that has not res…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New hope for Hard-to-Treat prostate cancer: experimental drug combo trial opens
Disease control Recruiting nowSubstudy 01A is part of a larger research study that is testing experimental treatments for metastatic castration-resistant prostate cancer (mCRPC). The larger study is the umbrella study (U01). The goal of substudy 01A is to evaluate the safety and efficacy of opevesostat-based…
Phase 1/2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a cocktail of good bacteria break the cycle of c. diff?
Disease control Recruiting nowThe overall objective of the RESTORATiVE303 study is to evaluate the safety and the Clostridioides difficile infection (CDI) recurrence rate at Week 8 in participants who receive a 14-day course of VE303 or matching placebo. The objectives and endpoints are identical for Stage 1 …
Phase 3 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
AI may predict which pelvic floor therapy works best
Knowledge-focused Recruiting nowThe goal of this observational study is to learn about the therapeutic effects of different pelvic floor rehabilitation treatments, including pelvic floor muscle training , pelvic floor biofeedback electrical stimulation, and magnetic stimulation, in a population of Chinese patie…
Sponsor: Mingfu Wu • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Lighter anesthesia may shield seniors from Post-Surgery confusion
Disease control Recruiting nowThe goal of this clinical trial (Balanced-2 study) is to compare light to deep general anesthesia using widely available brain monitors, to see if 'light' anesthesia could reduce rates of delirium, cognitive decline, and disability in older adults undergoing major surgery. Delir…
Sponsor: Auckland City Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Seizure drug may shield the brain after cardiac arrest — a trial puts it to the test
Prevention Recruiting nowBrain injury is the main cause of death and disability for patients surviving cardiac arrest resuscitation and seizures are diagnosed in up to a third of these patients. The investigators are proposing a pilot randomized placebo-controlled clinical trial to evaluate the safety an…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Prevention
Last updated Jul 31, 2026 00:00 UTC
-
Experimental drug duo targets Hard-to-Treat HER2 cancers
Disease control OngoingThis clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced …
Phase 2 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC